These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38603747)

  • 41. More Shots in Arms: Scalable Learnings From a Continuous Improvement Effort to Deliver COVID-19 Vaccinations in Small Community-Based Clinics.
    Lawson B; Clark S; Geraghty K; Poggetti J; Stewart J; Tarling P
    Disaster Med Public Health Prep; 2022 Apr; 17():e190. PubMed ID: 35361305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tracking Public Attitudes Toward COVID-19 Vaccination on Tweets in Canada: Using Aspect-Based Sentiment Analysis.
    Jang H; Rempel E; Roe I; Adu P; Carenini G; Janjua NZ
    J Med Internet Res; 2022 Mar; 24(3):e35016. PubMed ID: 35275835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identifying Associations Between Influenza Vaccination Status and Access, Beliefs, and Sociodemographic Factors Among the Uninsured Population in Suffolk County, NY.
    Chen G; Kazmi M; Chen D; Phillips J
    J Community Health; 2020 Dec; 45(6):1236-1241. PubMed ID: 32607750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The COVID-19 and Influenza "Twindemic": Barriers to Influenza Vaccination and Potential Acceptance of SARS-CoV2 Vaccination in African Americans.
    Ferdinand KC; Nedunchezhian S; Reddy TK
    J Natl Med Assoc; 2020 Dec; 112(6):681-687. PubMed ID: 33276969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics - United States, September 1, 2022-September 30, 2023.
    El Kalach R; Jones-Jack N; Elam MA; Olorukooba A; Vazquez M; Stokley S; Meyer S; McGarvey S; Nguyen K; Scharf LG; Harris LQ; Duggar C; Moore LB
    MMWR Morb Mortal Wkly Rep; 2024 Apr; 73(13):286-290. PubMed ID: 38573866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. County-Level Factors Associated With Influenza and COVID-19 Vaccination in Indiana, 2020‒2022.
    Kasting ML; Laily A; Burney HN; Head KJ; Daggy JK; Zimet GD; Schwab-Reese LM
    Am J Public Health; 2024 Apr; 114(4):415-423. PubMed ID: 38386970
    [No Abstract]   [Full Text] [Related]  

  • 47. Best Practices for COVID-19 Mass Vaccination Clinics.
    Shakory S; Eissa A; Kiran T; Pinto AD
    Ann Fam Med; 2022; 20(2):149-156. PubMed ID: 35346931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Developing a Community-Oriented and Place-Based Strategy to Improve COVID-19 Vaccine Accessibility.
    Swope M; Alem AC; Russo SC; Gin NE; Chevez SG; Haque R
    Perm J; 2023 Mar; 27(1):103-112. PubMed ID: 36911890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Collective Action: The Medical College of Wisconsin COVID-19 Vaccination Program.
    Sanchez AM; Busse K; MacKinnon K; Henk L; MacKinnon GE; Brown J; Mauermann S; Dobrowski T; Jungmann J; Bultman J; Singh S; Nattinger AB
    WMJ; 2021 Dec; 120(4):305-308. PubMed ID: 35025179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marketing mobile influenza vaccine clinics on a college campus.
    Hannings AN; Darley A; Kearney JC; Upchurch BL; Groft K
    J Am Pharm Assoc (2003); 2022; 62(2):551-554.e1. PubMed ID: 34776337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.
    Wong CA; Dowler S; Moore AF; Sosne EF; Young H; Tenenbaum JD; Burns CE; Jones S; Smelyanskaya M; Kinsley KH
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(28):991-996. PubMed ID: 34264909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. If we know better, why don't we do better? A rapid quality improvement project to increase utilization of comfort measures to reduce pain and distress in children in a COVID-19 mass vaccination clinic.
    Killian HJ; Deacy A; Edmundson E; Raab L; Schurman JV
    J Pediatr Nurs; 2024; 76():e93-e100. PubMed ID: 38307756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19 Mass Vaccination and Flu Season: Concern for Decreased Public Health Measures and Worsening the Influenza Situation.
    Kenarkoohi A; Mohamadi J; Pakzad I; Sayyadi H; Falahi S
    Infect Disord Drug Targets; 2023; 23(1):e030922208520. PubMed ID: 36056829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ethnic and minority group differences in engagement with COVID-19 vaccination programmes - at Pandemic Pace; when vaccine confidence in mass rollout meets local vaccine hesitancy.
    Reid JA; Mabhala MA
    Isr J Health Policy Res; 2021 May; 10(1):33. PubMed ID: 34044891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meharry Medical College Mobile Vaccination Program: Implications for Increasing COVID-19 Vaccine Uptake among Minority Communities in Middle Tennessee.
    Alcendor DJ; Juarez PD; Matthews-Juarez P; Simon S; Nash C; Lewis K; Smoot D
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding Questions and Concerns Regarding COVID-19 and the COVID-19 Vaccine Among Populations Presenting at a COVID-19 Vaccine Clinic Hub: A Qualitative Study.
    Krishnakumar HN; Gealogo GA; Holland T; Martinez M; Hendrix L; Collins M; Donate M; England M; Kumana E; Garcia J; Wilkey A; Akula N; Mai A; Patel DI
    J Prim Care Community Health; 2022; 13():21501319221118477. PubMed ID: 35997326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delivering COVID-19 Vaccine via Trusted Social Services: Program Evaluation Results from the Chicagoland CEAL Program.
    Martin MA; Cook S; Spring B; Echeverria Garcia JC; Moskowitz D; Delaughter-Young J; Silva A; Hartstein M; De Pablo M; Peek M; Lynch E; Battalio S; Vu M;
    J Community Health; 2024 Feb; 49(1):61-69. PubMed ID: 37438456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of the "immunization islands" model to improve quality, efficiency and safety of a COVID-19 mass vaccination site.
    Signorelli C; Odone A; Gianfredi V; Capraro M; Kacerik E; Chiecca G; Scardoni A; Minerva M; Mantecca R; Musarò P; Brazzoli P; Basteri P; Bertini B; Esposti F; Ferri C; Alberti VA; Gastaldi G
    Ann Ig; 2021; 33(5):499-512. PubMed ID: 34113956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maternal vaccination provision in NHS maternity trusts across England.
    Anderson EC; Blair PS; Finn A; Ingram J; Amirthalingam G; Cabral C
    Vaccine; 2023 Nov; 41(49):7359-7368. PubMed ID: 37951792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishment and evaluation of scalable COVID-19 vaccine clinics at a large university.
    Garofoli GK; Gálvez-Peralta M; Barrickman AL; Goodhart AL; Johnson H; McMillan AN; Elswick BM; Newmeyer ES; Burrell CN; Capehart KD; Petros WP
    J Am Pharm Assoc (2003); 2022; 62(4):1430-1437. PubMed ID: 35461778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.